John Armitage - Egerton Capital (UK) LLP
Holding/activity history for Gilead Sciences (GILD)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2016 Q3 | 0 | 0.00 | Sell 100.00% | 1.31 | SEC | ||
| 2016 Q2 | 1,397,732 | 1.31 | Reduce 69.09% | 2.89 | $83.42 | $116,599,000 | SEC |
| 2016 Q1 | 4,521,685 | 4.18 | Add 5.36% | 0.21 | $91.86 | $415,362,000 | SEC |
| 2015 Q4 | 4,291,467 | 4.78 | Reduce 23.24% | 1.52 | $101.19 | $434,254,000 | SEC |
| 2015 Q3 | 5,590,796 | 6.54 | Add 39.79% | 1.86 | $98.19 | $548,960,000 | SEC |
| 2015 Q2 | 3,999,454 | 6.37 | Add 406.01% | 5.11 | $117.08 | $468,256,000 | SEC |
| 2015 Q1 | 790,397 | 1.15 | Reduce 31.67% | 0.50 | $98.13 | $77,562,000 | SEC |
| 2014 Q4 | 1,156,764 | 1.57 | Reduce 79.70% | 6.92 | $94.26 | $109,037,000 | SEC |
| 2014 Q3 | 5,699,320 | 8.68 | Reduce 7.31% | 0.63 | $106.45 | $606,693,000 | SEC |
| 2014 Q2 | 6,148,743 | 8.63 | Buy | 8.63 | $82.91 | $509,792,000 | SEC |